Linkoeping University
Linköping, 58183, Sweden
NCT Number: NCT02895451
The purpose of this study is to investigate the effects of an extended behavioral intervention in exercise-based CR for improvement of physical capacity, adherence, psychological and physiological parameters, compared with usual care.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Linköping, 58183, Sweden
Consecutive patients will be included at the coronary care unit (CCU), Linköping University Hospital, Sweden. Physiotherapists ask patients for informed consent at the CCU and book an appointment at the exercise-based CR 2-3 weeks after discharge for baseline tests. After baseline testing patients will be randomized to either extended intervention or routine care. Randomization will be stratified by submaximal exercise capacity. Patients randomized to the extended intervention group receive an additional appointment to a physiotherapist within a week. Thereafter patients in both groups start the exercise-based CR program, including aerobic exercise and resistance exercise, 3 times/week for 16 weeks, according to international guidelines for exercise-based CR.
The extended intervention is based on components from behavioral medicine including: specific goal-setting, self-monitoring and feed-back.
Changes in the endpoint variables will be measured from baseline to first (16 weeks at end of intervention) and second (12 months after index event) follow-up visits.
Sample size calculations are based on previous clinical data from a similar exercise-based CR setting (n=50) on differences in aerobic exercise capacity measured by submaximal exercise test (watts) before vs after finished exercise-based CR. With a power of 80% and a two-sided significance level of p<0.05 and least mean difference at 10 watts (SD 20 watts) and a calculated loss of follow-up of 20%, the estimated sample size is 160 patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The exercise goal is set in liaison between the patient and the physiotherapist, based on activities and target behaviors that the patient thinks is relevant and important. The patients are asked to self-monitor the defined exercise goal by completing an exercise diary. The exercise diary includes specification of the performed exercise dose (frequency, intensity and duration). The exercise diary is followed up by a physiotherapist every third week by a phone call or a personal meeting. Visual feed-back on the performed dose of exercise is given once by accelerometry. At end of intervention (16 weeks) the patient is offered a follow-up meeting with the physiotherapist to discuss a long-term exercise goal.
Time frame: 4 months
The test is performed on a bicycle ergometer according to the WHO-protocol with an increased workload of 25W every 4.5 minutes.The exercise test is discontinued at Borg RPE 17 and/or dyspnea 7 at Borg´s CR-10 scale.
Time frame: 4 months
accelerometer
Time frame: 4 months
exercise diary
Time frame: 4 months
Muscle endurance test
Time frame: 4 months
Muscle endurance test
Time frame: 4 months
Hospital Anxiety and Depression Scale (HADS)
Time frame: 4 months
Hospital Anxiety and Depression Scale (HADS)
Time frame: 4 months
Self Efficacy Exercise Scale (SEE-SV)
Time frame: 4 months
Short-Form-36 (SF-36)
Time frame: 4 months
EQ5D
Time frame: 4 months
Accelerometer
Time frame: 4 months
Bouchard questionnaire
Time frame: 12 months
Submaximal exercise test on bicycle ergometer
Time frame: 12 months
Accelerometer
Time frame: 12 months
Exercise diary
Time frame: 12 months
Muscle endurance test
Time frame: 12 months
Muscle endurance test
Time frame: 12 months
Hospital Anxiety and Depression Scale (HADS)
Time frame: 12 months
Hospital Anxiety and Depression Scale (HADS)
Time frame: 12 months
Self Efficacy Exercise Scale (SEE-SV)
Time frame: 12 months
Short-Form-36 (SF-36)
Time frame: 2 months
EQ5D
Time frame: 12 months
accelerometer
Time frame: 12 months
Bouchard questionnaire
Time frame: 12 months
Patient Enablement Instrument (PEI)
Linkoeping University
Other Gov
Acronym: ECRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details